RI
CNTA

RTW Investments’s Centessa Pharmaceuticals CNTA Stock Holding History

RTW Investments’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.6M Buy
2,054,175
+263,338
+15% +$6.74M 0.81% 34
2025
Q4 		$44.8M Sell
1,790,837
-500,910
-22% -$12.7M 0.45% 50
2025
Q3 		$55.6M Buy
2,291,747
+761,911
+50% +$13.5M 0.68% 37
2025
Q2 		$20.1M Buy
1,529,836
+1,479,836
+2,960% +$18.7M 0.29% 49
2025
Q1 		$719K Hold
50,000
– – 0.01% 66
2024
Q4 		$838K Hold
50,000
– – 0.01% 70
2024
Q3 		$800K Buy
+50,000
New +$613K 0.01% 65

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RTW Investments's CNTA Position: Q1 2026 in Review

RTW Investments increased its Centessa Pharmaceuticals (CNTA) stake by 15% in Q1 2026, buying an estimated $6.74M and bringing the position to 2,054,175 shares worth $81.6M. The position accounts for 0.81% of the portfolio, ranked #34.

RTW Investments first reported a position in CNTA in Q3 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • RTW Investments held 2,054,175 shares of Centessa Pharmaceuticals worth $81.6M as of Q1 2026.
  • RTW Investments bought 263,338 Centessa Pharmaceuticals shares in Q1 2026, an estimated $6.74M.
  • Centessa Pharmaceuticals made up 0.81% of RTW Investments's portfolio in Q1 2026, its #34 holding.
  • RTW Investments first reported a position in Centessa Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.